Serum concentrations of ultrasensitive C-reactive protein and lipid profile in obese adolescents

Authors

  • Gerardo Fernández Soto
  • Carolina Arráiz de Fernández
  • Nereida Valero
  • Gerardo Fernández Arráiz

Keywords:

adolescents, obesity abdominal, C-reactive protein, dyslipidemias

Abstract

Introduction: obesity is an excess of adiposity characterized by a low-grade inflammatory state due to an increase in proteins in the acute phase. Objective: to determine serum concentrations of High Sensitivity C-Reactive Protein (hsCRP) and lipid profile in obese adolescents. Methodology: prospective, descriptive and cross-sectional study, with a simple randomized method of 225 obese adolescents, of both sexes and a control group of 100 eutrophic adolescents, evaluated by anthropometry with the curves of the World Health Organization and biochemical tests such as concentrations serum High Sensitivity C-Reactive Protein  by ELISA technique; total cholesterol, high-density lipoprotein and triglycerides, by dry analytical methodology and low-density lipoprotein by the Friedewald Formula: LDL (mmol/L)=total cholesterol -(TG/5)-HDL, the statistical analysis is performed with percentages, standard deviation and Student's t test considering statistical significance values ​​of p<0.05. Results: in males there is a significant difference in weight, waist circumference and an increase in hsCRP of 4.8±1.6 mg/L, dyslipidemia with a significant difference in high-density hypolipoproteinemia and hypertriglyceridemia with the others lipid profile parameters, in addition to a high cardiovascular risk with hsCRP levels above 3 mg/L. Conclusions: adolescents present central adiposity with high percentiles of waist circumference, components of the lipid triad (hypertriglyceridemia, high-density hypolipoprotinemia and low-density hyperlipoprotinemia) significant increase in hsCRP as biomarkers of cardiovascular risk.

Downloads

Download data is not yet available.

References

Mazzon E, Vinci F, Zuccotti G, Fabiano V, Cena H. Inflammation in Obesity-Related Complications in Children: The Protective Effect of Diet and Its Potential Role as a Therapeutic Agent. Biomolecules. 2020 Sep 16;10(9):E1324. doi: 10.3390/biom10091324. PMID: 32947869.

Wiciński M, Gębalski J, Gołębiewski J, Malinowski B. Probiotics for the Treatment of Overweight and Obesity in Humans-A Review of Clinical Trials. Microorganisms. 2020 Jul 29;8(8):1148. doi: 10.3390/microorganisms8081148. PMID: 32751306; PMCID: PMC7465252.

Jung UJ, Choi M-S. Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 2014;15(4):6184-6223. doi:10.3390/ijms15046184. PubMed PMID: 24733068; PubMed Central PMCID: PMC4013623.

Partridge, S. R., Juan, S. J.-H., McGeechan, K., Bauman, A. and Allman-Farinelli, M. Poor quality of external validity reporting limits generalizability of overweight and/or obesity lifestyle prevention interventions in young adults: a systematic review. Obesity Reviews. 2015;16(1):13-31,doi: 10.1111/obr.12233; PubMed PMID: 25407633.

Berry R, Jeffery E, Rodeheffer MS. Weighing in on Adipocyte Precursors. Cell metabolism. 2014;19(1):8-20, doi:10.1016/j.cmet.2013.10.003. Epub 2013 Nov 14. Review. PubMed PMID: 24239569; PubMed Central PMCID: PMC3947170.

Barr-Anderson, D. J., Singleton, C., Cotwright, C. J., Floyd, M. F. and Affuso, O. Outside-of-school time obesity prevention and treatment interventions in African American youth. Obesity Reviews. 2014;15: 26–45. doi: 10.1111/obr.12204 Review. PubMed PMID: 25196405.

Leary SD, Lawlor DA, Davey Smith G, Brion MJ, Ness AR. Behavioural early-life exposures and body composition at age 15 years. Nutr Diabetes. 2015; 9(5):e150, doi: 10.1038/nutd.2014.47. PubMed PMID: 25664839; PubMed Central PMCID: PMC4338416.

Etienne, Carissa F. Countries pledge action to reduce child obesity in the America. The Lancet. 2014 ;384(9959):2021. doi: 10.1016/S0140-6736(14)62328-X. PubMed PMID: 25483160.

MacLean PS, Higgins JA, Giles ED, Sherk VD, Jackman MR. The role for adipose tissue in weight regain after weight loss. Obesity Reviews. 2015;16(1):45-54. doi:10.1111/obr.12255. PubMed PMID: 25614203; PubMed Central PMCID: PMC4371661.

Jebeile H, Kelly AS, O'Malley G, Baur LA. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol. 2022 May;10(5):351-365. doi: 10.1016/S2213-8587(22)00047-X. Epub 2022 Mar 3. PMID: 35248172.

Matthew A. Sabin, Mrcpch (Uk), Fracp, Wieland Kiess. Childhood obesity: Current and novel approaches. Best Practice & Research Clinical Endocrinology & Metabolism, 2015;29(3):327 – 338, doi: 10.1016/j.beem.2015.04.003. Epub 2015 Apr 22. Review. PubMed PMID: 26051294.

Sypniewska G. Laboratory assessment of cardiometabolic risk in overweight and obese children. Clin Biochem. 2015 Apr;48(6):370-6. doi: 10.1016/j.clinbiochem.2014.12.024. Epub 2015 Jan 10. Review. PubMed PMID:

Schargrodsky, Herman, Hernández-Hernández R, Champagne BM, Silva H, Vinueza R, Silva Ayçaguer LC, Touboul PJ, Boissonnet CP, Escobedo J, F Pellegrini, Macchia A, Wilson E. CARMELA: Assessment of Cardiovascular Risk in Seven Latin American Cities. The American Journal of Medicine, 2008;121(1): 58 – 65, doi: 10.1016/j.amjmed.2007.08.038. PubMed PMID: 18187074.

Instituto Nacional de Nutrición (INN). Primer Estudio Nacional: Prevalencia de sobrepeso, obesidad y factores exógenos condicionantes en la población de 7 a 40 años. Venezuela 2008-2009. Resultados preliminares. Caracas: Segundo Encuentro para la Nutrición Social. 2010.

Cai Z, Huang Y, He B. New Insights into Adipose Tissue Macrophages in Obesity and Insulin Resistance. Cells. 2022 Apr 22;11(9):1424. doi: 10.3390/cells11091424. PMID: 35563728;

Cipolletta D, Feuerer M, Li A, Kamei N, Lee J, Shoelson SE, Benoist C, Mathis D. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature. 2012 Jun 28;486(7404):549-53. doi: 10.1038/nature11132. PMID: 22722857; PMCID: PMC3387339.

Martos-Moreno GA, Kopchick JJ, Argente J. [Adipokines in healthy and obese children]. An Pediatr (Barc). 2013;78(3):189.e1-189.e15. doi: 10.1016/j.anpedi.2012.10.008. Epub 2012 Nov 24. Review. Spanish. PubMed PMID: 23228441; PubMed Central PMCID: PMC4307602.

Al-Daghri NM, Al-Attas OS, Krishnaswamy S, Mohammed AK, Alenad AM, Chrousos GP, Alokail MS. Association of Type 2 Diabetes Mellitus related SNP genotypes with altered serum adipokine levels and metabolic syndrome phenotypes. Int J Clin Exp Med. 2015;8(3):4464-71. eCollection 2015. PubMed PMID: 26064370.

Choi MJ, Jung SB, Chang JY, Shong M. Cellular and Intercellular Homeostasis in Adipose Tissue with Mitochondria-Specific Stress. Endocrinol Metab (Seoul). 2021 Feb;36(1):1-11. doi: 10.3803/EnM.2021.956. Epub 2021 Feb 24. PMID: 33677920; PMCID: PMC7937835.

Netzer N, Gatterer H, Faulhaber M, Burtscher M, Pramsohler S, Pesta D. Hypoxia, Oxidative Stress and Fat. Biomolecules. 2015;5(2):1143-1150. Review. PubMed PMID: 26061760.

Ghoshal K, Bhattacharyya M. Adiponectin: Probe of the molecular paradigm associating diabetes and obesity. World Journal of Diabetes. 2015;6(1):151-166. doi:10.4239/wjd.v6.i1.151. Review. PubMed PMID: 25685286; PubMed Central PMCID:PMC4317307.

Robinson K, Prins J, Venkatesh B. Clinical review: adiponectin biology and its role in inflammation and critical illness. Crit Care. 2011;15(2):221. doi: 10.1186/cc10021. Review. PubMed PMID: 21586104; PubMed Central PMCID: PMC3219307.

Winer JC, Zern TL, Taksali SE, Dziura J, Cali AM, Wollschlager M, Seyal AA, Weiss R, Burgert TS, Caprio S. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab. 2006;91(11):4415-23. Epub 2006 Aug 22. PubMed PMID: 16926246.

Devaraj S, Torok N, Dasu MR, Samols D, Jialal I. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1368-74. doi: 10.1161/ATVBAHA.108.163303. Epub 2008 May 1. PubMed PMID: 18451326; PubMed Central PMCID: PMC2771588.

Murdolo G, Nowotny B, Celi F, et al. Inflammatory Adipokines, High Molecular Weight Adiponectin, and Insulin Resistance: A Population-Based Survey in Prepubertal Schoolchildren. Shirihai O, ed. PLoS ONE. 2011;6(2):e17264. doi:10.1371/journal.pone.0017264. PubMed PMID: 21365005; PubMed Central PMCID: PMC3041818.

Kim J-Y, Ahn SV, Yoon J-H, et al. Koh SB, Yoon J, Yoo BS, Lee SH, Park JK, Choe KH,Guallar E. Prospective Study of Serum Adiponectin and Incident Metabolic Syndrome: The ARIRANG study. Diabetes Care. 2013;36(6):1547-1553. doi:10.2337/dc12-0223. Epub 2012 Dec 28. PubMed PMID: 23275369; PubMed Central PMCID:PMC3661834.

Pires A, Martins P, Pereira AM, Marinho J, Vaz Silva P, Marques M, Castela E, Sena C, Seiça R. Pro-inflammatory triggers in childhood obesity: correlation between leptin, adiponectin and high-sensitivity C-reactive protein in a group of obese Portuguese children. Rev Port Cardiol. 2014;33(11):691-7. doi: 10.1016/j.repc.2014.04.004. Epub 2014 Nov 11. PubMed PMID: 25448795.

Flechtner-Mors M, George SN, Oeztuerk S, Haenle MM, Koenig W, Imhof A, Boehm BO, Graeter T, Mason RA, Kratzer W, Akinli AS; EMIL-Study group. Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample. BMC Res Notes. 2014;3(7):207. doi: 10.1186/1756-0500-7-207. PubMed PMID: 24693952; PubMed Central PMCID: PMC3977975.

Lourenço BH, Cardoso MA, for the ACTION Study Team. C-Reactive Protein Concentration Predicts Change in Body Mass Index during Childhood. PLoS ONE.2014; 9(3): e90357. doi: 10.1371/journal.pone.0090357. eCollection 2014. PubMed PMID: 24603645; PubMed Central PMCID: PMC3946086.

Rutkowski JM, Halberg N, Wang QA, Holland WL, Xia JY, Scherer PE. Differential transendothelial transport of adiponectin complexes. Cardiovascular Diabetology. 2014;13:47. doi:10.1186/1475-2840-13-47. PubMed PMID: 24552349; PubMed Central PMCID: PMC3932731.

Vizentin, N. P., Cardoso, P., Maia, C., Alves, I. P., Aranha, G. L., & Giannini, D. T. (2019). Dyslipidemia in Adolescents Seen in a University Hospital in the city of Rio de Janeiro/Brazil: Prevalence and Association. Arquivos brasileiros de cardiologia, 112(2), 147–151. https://doi.org/10.5935/abc.20180254

Perak AM, Ning H, Kit BK, de Ferranti SD, Van Horn LV, Wilkins JT, Lloyd-Jones DM. Trends in Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999-2016. JAMA. 2019 May 21;321(19):1895-1905. doi: 10.1001/jama.2019.4984. PMID: 31112258; PMCID: PMC6537842.

Francisco López-Jiménez, Mery Cortes-Bergoderi. Obesity and the Heart. Rev Esp Cardiol. 2011;64(2):140–149.

Arroyo-Espliguero R, Viana-Llamas MC, Silva-Obregón A, Avanzas P. The Role of C-reactive Protein in Patient Risk Stratification and Treatment. Eur Cardiol. 2021 Jul 7;16:e28. doi: 10.15420/ecr.2020.49. PMID: 34276813; PMCID: PMC8280753.

WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development. Geneva: World Health Organization, 2006. Disponible en:https://www.who.int/childgrowth/standards/technical_report/en/

Laboratory Procedure Manual Analyte: High Sensitivity C-Reactive Protein (HS-CRP) Matrix: Frozen Serum Method: Beckman UniCel® DxC 600 Synchron & Beckman UniCel® DxC 660i Synchron A, NHANES 2015-2016

Araujo María B, Casavalle Patricia, Tonietti Miriam. Consenso sobre manejo de las dislipidemias en pediatría. Arch Argent Pediatr.2015;113(2):177-186. http://dx.doi.org/10.5546/aap.2015.177

Reglamento Dirección de Investigación y Desarrollo. Política, normativas y procedimientos. Dirección de Investigación y Desarrollo-DIDE. Universidad Técnica de Ambato. 2014.Resolución 1593-C

Briceño-Iragorry Leopoldo, Valero B Gabriela, Briceño Alexandra. Gac Méd Caracas 2012;120(2):128-134

López de Blanco, Mercedes; Landaeta- Jiménez, Maritza y Macías de Tomei, Coromoto. Contribución del crecimiento prenatal y posnatal temprano en las enfermedades crónicas relacionadas con la nutrición. An Venez Nutr [online].2013;26 (1):26-39.

Sapunar, Jorge, Aguilar-Farías, Nicolás, Navarro, Juan, Araneda, Gustavo, Chandía-Poblete, Damian, Manríquez, Víctor, Brito, Roberto y Cerda, Álvaro. Alta prevalencia de dislipidemia y alto índice aterogénico de plasma en niños y adolescentes. Revista médica de Chile. 2018;146 (10),1112-1122. https://dx.doi.org/10.4067/S0034-98872018001001112

Brzeziński, M., Metelska, P., Myśliwiec, M., & Szlagatys-Sidorkiewicz, A. Lipid disorders in children living with overweight and obesity- large cohort study from Poland. Lipids in health and disease.2020;19(1),47. https://doi.org/10.1186/s12944-020-01218-6

Grossman, D. C., Bibbins-Domingo, K., Curry, S. J., Barry, M. J., Davidson, K. W., Doubeni, C. A., Epling, J. W., Jr, Kemper, A. R., Krist, A. H., Kurth, A. E., Landefeld, C. S., Mangione, C. M., Phipps, M. G., Silverstein, M., Simon, M. A., & Tseng, C. W. Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA:2017;317(23), 2417–2426.

Malo-Serrano, Miguel, Castillo M, Nancy, & Pajita D, Daniel. La obesidad en el mundo. Anales de la Facultad de Medicina.2017;78(2),173-178. https://dx.doi.org/10.15381/anales.v78i2.13213

Del Águila Villar, Carlos M. Obesidad en el niño: factores de riesgo y estrategias para su prevención en Perú. Revista Peruana de Medicina Experimental y Salud Publica.2017;34(1), 113-118. https://dx.doi.org/10.17843/rpmesp.2017.341.2773

Bugge A, El-Naaman B, G McMurray R, Froberg K, Nielsen CH, Müller K, Andersen LB. Sex differences in the association between level of childhood interleukin-6 and insulin resistance in adolescence. Exp Diabetes Res. 2012;2012:859186. doi:10.1155/2012/859186. Epub 2012 Jan 5. PubMed PMID: 22272193; PubMed Central PMCID: PMC3261468.

Lee M-J, Wu Y, Fried SK. Adipose Tissue Heterogeneity: Implication of depot differences in adipose tissue for Obesity Complications. Molecular aspects of medicine. 2013;34(1):1-11. doi:10.1016/j.mam.2012.10.001.

Vahid F, Bourbour F, Gholamalizadeh M, Shivappa N, Hébert JR, Babakhani K, Mosavi Jarrahi A, Mirzaei Dahka S, Doaei S. A pro-inflammatory diet increases the likelihood of obesity and overweight in adolescent boys: a case-control study. Diabetol Metab Syndr. 2020 Apr 7;12:29. doi: 10.1186/s13098-020-00536-0. PMID: 32292493; PMCID: PMC7140561.

Ávila Flores, Monserrat y Nava Uribe, Emilio.Frecuencia de dislipidemia en pacientes pediátricos con sobrepeso y obesidad. Acta méd. Grupo Ángeles.2016.,14(3):147-154

Santos ASAC, Rodrigues APS, Rosa LPS, Sarrafzadegan N, Silveira EA. Cardiometabolic risk factors and Framingham Risk Score in severely obese patients: Baseline data from DieTBra trial. Nutr Metab Cardiovasc Dis. 2020 Mar 9;30(3):474-482. doi: 10.1016/j.numecd.2019.10.010. Epub 2019 Nov 5. PMID: 31791637.

Nyangasa MA, Buck C, Kelm S, Sheikh MA, Günther K, Hebestreit A. The association between leptin and inflammatory markers with obesity indices in Zanzibari children, adolescents, and adults. Obes Sci Pract. 2020 Nov 4;7(1):71-81. doi: 10.1002/osp4.466. PMID: 33680494; PMCID: PMC7909594.

Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022 Jul;22(7):429-443. doi: 10.1038/s41577-021-00639-3. Epub 2021 Nov 5. PMID: 34741169; PMCID: PMC8570243.Wang P, Shao X, Bao Y, Zhu J, Chen L, Zhang L, Ma X, Zhong XB. Impact of obese levels on the hepatic expression of nuclear receptors and drug-metabolizing enzymes in adult and offspring mice. Acta Pharm Sin B. 2020 Jan;10(1):171-185. doi: 10.1016/j.apsb.2019.10.009. Epub 2019 Nov 28. PMID: 31993314; PMCID: PMC6976990.

Kwaifa IK, Bahari H, Yong YK, Noor SM. Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications. Biomolecules. 2020 Feb 13;10(2):291. doi: 10.3390/biom10020291. PMID: 32069832; PMCID: PMC7072669

Haro Acosta María Elena, Ruiz-Esparza Cisneros Josefina, Díaz Molina Raúl, Ayala Figueroa Rafael Iván, Delgado Jesús Hernán. Asociación de la proteína C-reactiva ultrasensible con la composición de la dieta en niños escolares mexicanos. Invest. clín. 2017; 58(1):044-055. Disponible en: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0535-51332017000100005&lng=es.

Michels KB, Keller K, Pereira A, Kim CE, Santos JL, Shepherd J, Corvalan C, Binder AM. Association between indicators of systemic inflammation biomarkers during puberty with breast density and onset of menarche. Breast Cancer Res. 2020 Oct 1;22(1):104. doi: 10.1186/s13058-020-01338-y. PMID: 33004039; PMCID: PMC7531086.

Brito Viviana, Andrea Alcaraz, Federico Augustovski, Andrés Pichón-Riviere, Sebastián García-Martí, Ariel Bardach, Agustín Ciapponi, Analía López, Daniel Comandé y Grupo de Evaluación de Tecnologías Sanitarias. High sensitivity C protein as an independent risk factor in people with and without history of cardiovascular disease. Arch Cardiol Mex. 2015;85(2):124---135. doi: 10.1016/j.acmx.2014.11.005

Published

2023-04-06

How to Cite

Fernández Soto, G. ., Arráiz de Fernández, C. ., Valero, N. ., & Fernández Arráiz, G. . (2023). Serum concentrations of ultrasensitive C-reactive protein and lipid profile in obese adolescents. AVFT – Archivos Venezolanos De Farmacología Y Terapéutica, 41(5). Retrieved from http://caelum.ucv.ve/ojs/index.php/rev_aavft/article/view/25975